ghk-cu peptide cons A Dermatologist's Take on the Copper (GHK-Cu) Trend The Risks of Using GHK-Cu

Treatment-Resistant Tendinopathy Patients: Individuals whose chronic tendinopathy has not responded to 6 or more months of physical therapy, corticosteroid injections, and NSAIDs are likely to explore unproven adjunct options (BPC-157)

The fix: maintain at least 3 sites in rotation, ideally 5-6

You should also go over all medications you currently take, such as glucose-lowering diabetes medications, blood pressure or thyroid meds, or anticoagulants

These are self-reported accounts, not findings from controlled studies

This is verified via HPLC and mass spectrometry, with complete results documented on the included Certificate of Analysis

Published 2021 May 26